The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 20, 2022

Filed:

Mar. 01, 2019
Applicant:

Inflazome Limited, Dublin, IE;

Inventors:

Matthew Cooper, Cambridge, GB;

David Miller, Cambridge, GB;

Jimmy Van Wiltenburg, Groningen, NL;

Assignee:

INFLAZOME LIMITED, Dublin, IE;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 405/04 (2006.01); C07D 231/20 (2006.01); C07D 233/84 (2006.01); C07D 249/04 (2006.01); C07D 401/12 (2006.01); C07D 405/14 (2006.01);
U.S. Cl.
CPC ...
C07D 405/04 (2013.01); C07D 231/20 (2013.01); C07D 233/84 (2013.01); C07D 249/04 (2013.01); C07D 401/12 (2013.01); C07D 405/14 (2013.01);
Abstract

The present invention relates to compounds of formula (I), wherein Q is selected from O or S; Ris a 5- or 6-membered heteroaryl group consisting of one or more carbon atoms, and one or more nitrogen and/or oxygen atoms, and substituted with a monovalent, optionally substituted cycloalkyl, cycloalkenyl or heterocyclic group, wherein the 5- or 6-membered heteroaryl group of Rmay optionally be further substituted; Ris an α,α'-substituted cyclic group which may optionally be further substituted; Rand Rare each independently hydrogen, halogen, —OH, —NH, —CN, —R, —OR, —NHRor —N(R); or Rand Rtogether with the carbon atom to which they are attached may form a 3- to 7-membered saturated or unsaturated, optionally substituted cyclic group; and Ris independently an optionally substituted C-Calkyl group. The present invention further relates to salts, solvates and prodrugs of such compounds, to pharmaceutical compositions comprising such compounds, and to the use of such compounds in the treatment and prevention of medical disorders and diseases, most especially by the inhibition of NLRP3.


Find Patent Forward Citations

Loading…